drugset / Trial / NCT03901235
MSC Intratissular Injection in Crohn Disease Patients
Phase 1/2
Recruiting
60 enrolled
University of Liege
Centre Hospitalier Universitaire de Liege · collab
NaSingle-groupOpen-labelTreatment
Summary
The main objective is to assess the efficacy of local injection of MSC on the healing of refractory intestinal and perianal lesions in crohn disease. The second co-primary endpoint is safety.
Timeline
- Start
- 2018-01-15
- Primary completion
- 2025-12-31
- Completion
- 2026-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | mesenchymal stem cells | Cell therapy | — | Other |
Indications
No indication recorded.